Kiromic BioPharma, Inc.
KRBPQ
$0.0615
-$0.083-57.44%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -28.40% | -7.60% | 29.47% | 33.27% | 39.68% |
| Total Depreciation and Amortization | 0.59% | 0.00% | 1.53% | 8.57% | 32.72% |
| Total Amortization of Deferred Charges | -- | -- | -197.82% | -188.86% | -100.00% |
| Total Other Non-Cash Items | 99.36% | -36.60% | -47.03% | -47.03% | -49.07% |
| Change in Net Operating Assets | 103.95% | 63.72% | -360.61% | -206.20% | -214.63% |
| Cash from Operations | 8.33% | -6.53% | -17.93% | -12.32% | 10.62% |
| Capital Expenditure | -76.81% | -188.02% | -533.51% | 90.49% | 95.76% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -76.81% | -218.83% | -461.42% | 90.43% | 95.75% |
| Total Debt Issued | -21.25% | -14.09% | 58.00% | 129.96% | 420.53% |
| Total Debt Repaid | 12.93% | 17.43% | -6.96% | -19.87% | -9.65% |
| Issuance of Common Stock | -- | -100.00% | -100.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 99.68% | 89.72% | 137.80% | 44.50% |
| Cash from Financing | -23.24% | -15.26% | 55.81% | 156.50% | 514.73% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -155.06% | -133.54% | 138.75% | 112.41% | 110.36% |